Observational study on CML patients in any phase treated with ponatinib (Iclusig®) at any dose - The Ponderosa Project

被引：0
|
作者：
Clauss, C. [1 ]
Fabisch, C. [1 ]
Ernst, T. [1 ]
Schenk, T. [1 ]
Saussele, S. [2 ]
Tesch, H. [3 ]
Mayer, J. [4 ]
Hochhaus, A. [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Internist Onkol, Jena, Germany
[2] Univ Med Mannheim, Med Klin 3, Hamatol & Internist Onkol, Mannheim, Germany
[3] Praxis Hamatol & Onkol, Frankfurt, Germany
[4] Ceska leukemicka Spolecnost Pro Zivot, Brno, Czech Republic
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P775
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [21] Has toxicity in young patients with Germ Cell Tumor (GCT) treated with High-Dose Chemotherapy (HDCT) any impact on weight?
    Giannotti, F
    Civinelli, MC
    Martelli, S
    Amati, P
    Peccenini, R
    Zambianchi, H
    Papiani, G
    De Giorgi, L
    Cavallaro, M
    Rosti, G
    Marangolo, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S389 - S389
  • [22] Is there any correlation between integrated pulmonary index and thoracic surgery patients' follow-up data? a prospective, observational study
    Abdulkarem, Zaid
    Turktan, Mediha
    Gulec, Ersel
    Hatipoglu, Zehra
    Binokay, Hulya
    Ozcengiz, Dilek
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (03): : 1044 - 1052
  • [23] Cardiovascular Hospitalization in Patients Treated with Dasatinib or Nilotinib in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients in Routine Clinical Practice
    Mauro, Michael J.
    Chen, Clara
    Cortes, Jorge E.
    Gambacorti-Passerini, Carlo
    Sen, Ginny P.
    Gajavelli, Srikanth
    Davis, Catherine
    Michallet, Mauricette
    BLOOD, 2018, 132
  • [24] Phase II study of Regorafenib as single agent for the treatment of patients with metastatic colorectal cancer with any RAS or BRAF mutation and previously treated with FOLFOXIRI plus bevacizumab
    Garcia Alfonso, P.
    Ortiz, M. J.
    Duran, G.
    Falco, E.
    Munoz, A.
    Garcia-Paredes, B.
    Salgado, M.
    Lopez-Ladron, A.
    Vieitez de Prado, J. M.
    Valladares, M.
    Salud, A.
    Guillen-Ponce, C.
    Lopez, R.
    Robles, L.
    Juarez, A.
    Serrano, S.
    Montagut, C.
    Zanui, M.
    Gil Raga, M.
    La Casta, A.
    Benavides, M.
    Aranda, E.
    ANNALS OF ONCOLOGY, 2015, 26
  • [25] Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
    Apostolia M Tsimberidou
    Rabih Said
    Kirk Culotta
    Ignacio Wistuba
    Jaroslav Jelinek
    Siqing Fu
    Gerald Falchook
    Aung Naing
    Sarina Piha-Paul
    Ralph Zinner
    Zahid H Siddik
    Guangan He
    Kenneth Hess
    David J Stewart
    Razelle Kurzrock
    Jean-Pierre J Issa
    Clinical Epigenetics, 2015, 7
  • [26] Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
    Tsimberidou, Apostolia M.
    Said, Rabih
    Culotta, Kirk
    Wistuba, Ignacio
    Jelinek, Jaroslav
    Fu, Siqing
    Falchook, Gerald
    Naing, Aung
    Piha-Paul, Sarina
    Zinner, Ralph
    Siddik, Zahid H.
    He, Guangan
    Hess, Kenneth
    Stewart, David J.
    Kurzrock, Razelle
    Issa, Jean-Pierre J.
    CLINICAL EPIGENETICS, 2015, 7 : 1 - 11
  • [27] 4-Year Results With Ponatinib by Mutation Status in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML): OPTIC Study
    Deininger, Michael
    Apperley, Jane
    Arthur, Christopher Kevin
    Chuah, Charles
    Hochhaus, Andreas
    de Lavallade, Hugues
    Lipton, Jeffrey
    Lomaia, Elza
    McCloskey, James
    Maness, Lori
    Mauro, Michael
    Moiraghi, Beatriz
    Pavlovsky, Carolina
    Rosti, Gianantonio
    Rousselot, Philippe
    Sutton, Maria Undurraga
    Ren, Xiaowei
    Vorog, Alexander
    Kantarjian, Hagop
    Cortes, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S353 - S354
  • [28] Do patients undergoing renal revascularization outside of the ASTRAL trial show any benefit? Results of a single-centre observational study
    Valluri, Achyut
    Severn, Alison
    Chakraverty, Sam
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (02) : 734 - 738
  • [29] Efficacy and safety of amlodipine/valsartan/hydrochlorothiazide single pill combination in Egyptian patients with hypertension uncontrolled on any dual therapy: an observational study
    El-Etriby, Adel Mohamed Kamal
    Rakha, Sameh
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 537 - 544
  • [30] Does gender have any role in intravenous rtPA-treated patients? Our experience from the TCD multicenter study
    Al-Hussain, Fawaz
    Hussain, Muhammad S.
    Ibrahim, Mohamed M.
    Uchino, Ken
    Molina, Carlos
    Khurshid, Khan A.
    Salam, Abdul
    Shuaib, Ashfaq
    Demchuk, Alexandrov M.
    Alexandrov, Andrei V.
    Saqqur, Maher
    STROKE, 2007, 38 (02) : 500 - 500
12345